David Sali

Dave is OBJ’s senior writer and editor with two decades of experience in the newspaper industry working for a variety of publications from community weeklies to major dailies. He is a four-time award-winning journalist by the Alliance of Area Business Publishers (AABP). He has received awards for best news feature, best scoop and best overall writer among medium-sized business publications.

Senior execs Forsyth, Frasca and Lemieux leaving Shopify

Techopia

Long-serving C-suite leaders are expected to end their lengthy tenures with the Ottawa-based e-commerce company in June.

Grade A-plus: Ottawa IT firm boosts U.S. presence with acquisition of Michigan company

Techopia

Deal comes hot on the heels of Grade A’s merger with Oregon’s Convergence Networks last December.

Fast-rising Field Effect sees big upside in local partnerships

Techopia

Cybersecurity startup’s headcount has already jumped 20 per cent since late December and now stands at 150.

Ottawa medical app-maker Vaultt partners with German pharma giant on data-sharing tool

Techopia

Startup hopes deal with Boehringer Ingelheim paves way for partnerships with other big health-care players as it launches $1M funding drive.

Ottawa’s Fastest Growing Companies: Pre-pandemic pivot pays off for bug-detection firm Noibu

Fastest Growing Companies

Noibu’s revenues soared nearly 600 per cent in 2020 as retailers realized that even minutes of selling time lost to glitches in their online stores

Leonovus boss ‘bullish’ on struggling Ottawa software firm’s future

Techopia

Company hopes decade-long effort to develop secure data-transfer technology will finally bear fruit after getting the green light to sell its products to the federal

Pythian acquires Chicago-area firm in bid to bolster cloud service offerings

Techopia

ManageServe specializes in working with customers who use software from suppliers such as SAP to manage various aspects of their business, from finance and HR

Spartan Bioscience files for creditor protection, lays off nearly 70% of staff

Techopia

Ottawa biotech firm says it is restructuring in the wake of a “higher-than-expected level of inconclusive results” from its rapid COVID-19 testing device.